Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. [electronic resource]
Producer: 20081204Description: 1640-8 p. digitalISSN:- 1558-3597
- Aged
- Aged, 80 and over
- Benzazepines -- therapeutic use
- Double-Blind Method
- Female
- Heart Failure -- drug therapy
- Hospitalization
- Humans
- Internationality
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Myocardial Revascularization
- Pacemaker, Artificial -- statistics & numerical data
- Prospective Studies
- Tolvaptan
- Vasopressins -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.